Follow the Clinigen money man
Pharmaceutical group Clinigen (CLIN:AIM) is forecast to report double-digit profit growth in each of the next three years. New chief financial officer (CFO) Martin Abell clearly likes the outlook enough to buy £100,000 worth of...
26 May 2016
